July 1, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Camarillo biotech company pursuing cancer treatments raises $20M

IN THIS ARTICLE

AskGene, a clinical-stage biopharmaceutical company focusing on immunotherapies for cancers and autoimmune diseases, closed a $20 million series A financing round in May, led by Qiming Venture Partners and TF Capital. With the funding, AskGene, which is dually based in Camarillo and China, will be focusing on building out its product pipeline. According to the…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.